{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T23:59:35Z","timestamp":1786665575537,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,6,12]],"date-time":"2015-06-12T00:00:00Z","timestamp":1434067200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s00210-015-1142-1","type":"journal-article","created":{"date-parts":[[2015,6,11]],"date-time":"2015-06-11T12:32:42Z","timestamp":1434025962000},"page":"1069-1077","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Calea zacatechichi dichloromethane extract exhibits antidiarrheal and antinociceptive effects in mouse models mimicking irritable bowel syndrome"],"prefix":"10.1007","volume":"388","author":[{"given":"M.","family":"Sa\u0142aga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kowalczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Zielinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"B\u0142a\u017cewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Fichna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,12]]},"reference":[{"issue":"1","key":"1142_CR1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2008-2231-22-9","volume":"22","author":"M Alipour","year":"2014","unstructured":"Alipour M, Khoobi M, Emami S, Fallah-Benakohal S, Ghasemi-Niri SF, Abdollahi M, Foroumadi A, Shafiee A (2014) Antinociceptive properties of new coumarin derivatives bearing substituted 3,4-dihydro-2H-benzothiazines. Daru 22(1):9\u201316","journal-title":"Daru"},{"key":"1142_CR2","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1136\/gut.2003.037697","volume":"53","author":"W Atkinson","year":"2004","unstructured":"Atkinson W, Sheldon TA, Shaath N, Whorwell PJ (2004) Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut 53:1459\u20131464","journal-title":"Gut"},{"key":"1142_CR3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0014-5793(96)01502-5","volume":"402","author":"PM Bork","year":"1997","unstructured":"Bork PM, Schmitz ML, Kuhnt M, Escher C, Heinrich M (1997) Sesquiterpene lactone containing Mexican Indian medicinal plants and pure sesquiterpene lactones as potent inhibitors of transcription factor NF-kappaB. FEBS Lett 402:85\u201390","journal-title":"FEBS Lett"},{"key":"1142_CR4","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1089\/acm.2004.10.1015","volume":"10","author":"R Bundy","year":"2004","unstructured":"Bundy R, Walker AF, Middleton RW, Booth J (2004a) Turmeric extract may improve irritable bowel syndrome symptomology in otherwise healthy adults: a pilot study. J Altern Complement Med 10:1015\u20131018","journal-title":"J Altern Complement Med"},{"key":"1142_CR5","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1089\/acm.2004.10.667","volume":"10","author":"R Bundy","year":"2004","unstructured":"Bundy R, Walker AF, Middleton RW, Marakis G, Booth JC (2004b) Artichoke leaf extract reduces symptoms of irritable bowel syndrome and improves quality of life in otherwise healthy volunteers suffering from concomitant dyspepsia: a subset analysis. J Altern Complement Med 10:667\u2013669","journal-title":"J Altern Complement Med"},{"key":"1142_CR6","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.dld.2007.02.006","volume":"39","author":"G Cappello","year":"2007","unstructured":"Cappello G, Spezzaferro M, Grossi L, Manzoli L, Marzio L (2007) Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial. Dig Liver Dis 39:530\u2013536","journal-title":"Dig Liver Dis"},{"key":"1142_CR7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0021-9673(94)80606-3","volume":"672","author":"D Chouchi","year":"1994","unstructured":"Chouchi D, Barth D (1994) Rapid identification of some coumarin derivatives in deterpenated citrus peel oil by gas chromatography. J Chromatogr A 672:177\u2013183","journal-title":"J Chromatogr A"},{"key":"1142_CR8","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.neuropharm.2011.07.021","volume":"61","author":"A Cravezic","year":"2011","unstructured":"Cravezic A, Fichna J, Gach K, Wyrebska A, Perlikowska R, Costentin J, Bonnet JJ, Janecka A, Do Rego JC (2011) Effect of potent endomorphin degradation blockers on analgesic and antidepressant-like responses in mice. Neuropharmacology 61:1229\u20131238","journal-title":"Neuropharmacology"},{"key":"1142_CR9","doi-asserted-by":"crossref","first-page":"G749","DOI":"10.1152\/ajpgi.00114.2007","volume":"293","author":"N Eijkelkamp","year":"2007","unstructured":"Eijkelkamp N, Kavelaars A, Elsenbruch S, Schedlowski M, Holtmann G, Heijnen CJ (2007) Increased visceral sensitivity to capsaicin after DSS-induced colitis in mice: spinal cord c-Fos expression and behavior. Am J Physiol Gastrointest Liver Physiol 293:G749\u2013G757","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1142_CR10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3389\/fphar.2012.00127","volume":"3","author":"J Fichna","year":"2012","unstructured":"Fichna J, Storr MA (2012) Brain-gut interactions in IBS. Front Pharmacol 3:127","journal-title":"Front Pharmacol"},{"key":"1142_CR11","doi-asserted-by":"crossref","first-page":"e550","DOI":"10.1111\/nmo.12158","volume":"25","author":"J Fichna","year":"2013","unstructured":"Fichna J, Sibaev A, Salaga M, Sobczak M, Storr M (2013) The cannabinoid-1 receptor inverse agonist taranabant reduces abdominal pain and increases intestinal transit in mice. Neurogastroenterol Motil 25:e550\u2013e559","journal-title":"Neurogastroenterol Motil"},{"key":"1142_CR12","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/nmo.12390","volume":"26","author":"J Fichna","year":"2014","unstructured":"Fichna J, Sobczak M, Mokrowiecka A, Cygankiewicz AI, Zakrzewski PK, Cenac N, Sa\u0142aga M, Timmermans JP, Vergnolle N, Ma\u0142ecka-Panas E, Krajewska WM, Storr M (2014a) Activation of the endogenous nociceptin system by selective nociceptin receptor agonist SCH 221510 produces antitransit and antinociceptive effect: a novel strategy for treatment of diarrhea-predominant IBS. Neurogastroenterol Motil 26:1539\u20131550","journal-title":"Neurogastroenterol Motil"},{"key":"1142_CR13","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/nmo.12272","volume":"26","author":"J Fichna","year":"2014","unstructured":"Fichna J, Sa\u0142aga M, Stuart J, Saur D, Sobczak M, Zatorski H, Timmermans JP, Bradshaw HB, Ahn K, Storr MA (2014b) Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid-like fatty acid amides. Neurogastroenterol Motil 26:470\u2013481","journal-title":"Neurogastroenterol Motil"},{"key":"1142_CR14","doi-asserted-by":"crossref","unstructured":"Gach K, do-Rego JC, Fichna J, Storr M, Delbro D, Toth G, Janecka A. (2010). Synthesis and biological evaluation of novel peripherally active morphiceptin analogs. Peptides 31: 1617-1624","DOI":"10.1016\/j.peptides.2010.04.018"},{"key":"1142_CR15","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1515\/znc-1996-7-815","volume":"51","author":"AS Galabov","year":"1996","unstructured":"Galabov AS, Iosifova T, Vassileva E, Kostova I (1996) Antiviral activity of some hydroxycoumarin derivatives. Z Naturforsch C 51:588\u2013562","journal-title":"Z Naturforsch C"},{"key":"1142_CR16","first-page":"4347","volume":"33","author":"M Kielbus","year":"2013","unstructured":"Kielbus M, Skalicka-Wozniak K, Grabarska A, Jeleniewicz W, Dmoszynska-Graniczka M, Marston A, Polberg K, Gawda P, Klatka J, Stepulak A (2013) 7-substituted coumarins inhibit proliferation and migration of laryngeal cancer cells in vitro. Anticancer Res 33:4347\u20134356","journal-title":"Anticancer Res"},{"key":"1142_CR17","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/01.mcg.0000155570.19340.61","volume":"39","author":"SC Kong","year":"2005","unstructured":"Kong SC, Hurlstone DP, Pocock CY, Walkington LA, Farquharson NR, Bramble MG, McAlindon ME, Sanders DS (2005) The incidence of self-prescribed oral complementary and alternative medicine use by patients with gastrointestinal diseases. J Clin Gastroenterol 39:138\u2013141","journal-title":"J Clin Gastroenterol"},{"key":"1142_CR18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0304-3959(01)00275-5","volume":"92","author":"JM Laird","year":"2001","unstructured":"Laird JM, Martinez-Caro L, Garcia-Nicas E, Cervero F (2001) A new model of visceral pain and referred hyperalgesia in the mouse. Pain 92:335\u2013342","journal-title":"Pain"},{"key":"1142_CR19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0378-8741(03)00188-0","volume":"88","author":"M Leonti","year":"2003","unstructured":"Leonti M, Sticher O, Heinrich M (2003) Antiquity of medicinal plant usage in two Macro-Mayan ethnic groups (Mexico). J Ethnopharmacol 88:119\u2013124","journal-title":"J Ethnopharmacol"},{"key":"1142_CR20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.carres.2012.05.013","volume":"357","author":"J Liu","year":"2012","unstructured":"Liu J, Chen L, Cai S, Wang Q (2012) Semisynthesis of apigenin and acacetin-7-O-beta-D-glycosides from naringin and their cytotoxic activities. Carbohydr Res 357:41\u201346","journal-title":"Carbohydr Res"},{"key":"1142_CR21","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s11894-010-0124-1","volume":"12","author":"N Manabe","year":"2010","unstructured":"Manabe N, Rao AS, Wong BS, Camilleri M (2010) Emerging pharmacologic therapies for irritable bowel syndrome. Curr Gastroenterol Rep 12:408\u2013416","journal-title":"Curr Gastroenterol Rep"},{"key":"1142_CR22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0378-8741(86)90002-4","volume":"18","author":"L Mayagoitia","year":"1986","unstructured":"Mayagoitia L, Diaz JL, Contreras CM (1986) Psychopharmacologic analysis of an alleged oneirogenic plant: Calea zacatechichi. J Ethnopharmacol 18:229\u2013243","journal-title":"J Ethnopharmacol"},{"key":"1142_CR23","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1053\/gast.2002.33584","volume":"122","author":"EA Mayer","year":"2002","unstructured":"Mayer EA, Collins SM (2002) Evolving pathophysiologic models of functional gastrointestinal disorders. Gastroenterology 122:2032\u20132048","journal-title":"Gastroenterology"},{"key":"1142_CR24","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s10620-009-0854-9","volume":"55","author":"S Merat","year":"2010","unstructured":"Merat S, Khalili S, Mostajabi P, Ghorbani A, Ansari R, Malekzadeh R (2010) The effect of enteric-coated, delayed-release peppermint oil on irritable bowel syndrome. Dig Dis Sci 55:1385\u20131390","journal-title":"Dig Dis Sci"},{"key":"1142_CR25","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1248\/bpb.b12-00905","volume":"36","author":"SH Park","year":"2013","unstructured":"Park SH, Sim YB, Kang YJ, Kim SS, Kim CH, Kim SJ, Lim SM, Suh HW (2013) Antinociceptive profiles and mechanisms of orally administered coumarin in mice. Biol Pharm Bull 36:925\u2013930","journal-title":"Biol Pharm Bull"},{"key":"1142_CR26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5415\/apallergy.2011.1.1.36","volume":"1","author":"H Philpott","year":"2011","unstructured":"Philpott H, Gibson P, Thien F (2011) Irritable bowel syndrome\u2014an inflammatory disease involving mast cells. Asia Pac Allergy 1:36\u201342","journal-title":"Asia Pac Allergy"},{"key":"1142_CR27","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3748\/wjg.v18.i7.589","volume":"18","author":"R Rahimi","year":"2012","unstructured":"Rahimi R, Abdollahi M (2012) Herbal medicines for the management of irritable bowel syndrome: a comprehensive review. World J Gastroenterol 18:589\u2013600","journal-title":"World J Gastroenterol"},{"key":"1142_CR28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1124\/jpet.114.214239","volume":"350","author":"M Sa\u0142aga","year":"2014","unstructured":"Sa\u0142aga M, Polepally PR, Sobczak M, Grzywacz D, Kamysz W, Sibaev A, Storr M, Do Rego JC, Zjawiony JK, Fichna J (2014) Novel orally available salvinorin A analog PR-38 inhibits gastrointestinal motility and reduces abdominal pain in mouse models mimicking irritable bowel syndrome. J Pharmacol Exp Ther 350:69\u201378","journal-title":"J Pharmacol Exp Ther"},{"key":"1142_CR29","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1053\/gast.2002.32978","volume":"122","author":"RS Sandler","year":"2002","unstructured":"Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, Gemmen E, Shah S, Avdic A, Rubin R (2002) The burden of selected digestive diseases in the United States. Gastroenterology 122:1500\u20131511","journal-title":"Gastroenterology"},{"key":"1142_CR30","doi-asserted-by":"crossref","first-page":"G119","DOI":"10.1152\/ajpgi.90274.2008","volume":"296","author":"A Sibaev","year":"2009","unstructured":"Sibaev A, Yuce B, Kemmer M, Van NL, Broedl U, Allescher HD, Goke B, Timmermans JP, Storr M (2009) Cannabinoid-1 (CB1) receptors regulate colonic propulsion by acting at motor neurons within the ascending motor pathways in mouse colon. Am J Physiol Gastrointest Liver Physiol 296:G119\u2013G128","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1142_CR31","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/gut.46.1.78","volume":"46","author":"WG Thompson","year":"2000","unstructured":"Thompson WG, Heaton KW, Smyth GT, Smyth C (2000) Irritable bowel syndrome in general practice: prevalence, characteristics, and referral. Gut 46:78\u201382","journal-title":"Gut"},{"key":"1142_CR32","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.bbrc.2008.02.018","volume":"368","author":"K Umemura","year":"2008","unstructured":"Umemura K, Itoh T, Hamada N, Fujita Y, Akao Y, Nozawa Y, Matsuura N, Iinuma M, Ito M (2008) Preconditioning by sesquiterpene lactone enhances H2O2-induced Nrf2\/ARE activation. Biochem Biophys Res Commun 368:948\u2013954","journal-title":"Biochem Biophys Res Commun"},{"key":"1142_CR33","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1055\/s-0030-1250584","volume":"77","author":"H Wu","year":"2011","unstructured":"Wu H, Fronczek FR, Burandt Jr CL, Zjawiony JK (2011) Antileishmanial germacranolides from Calea zacatechichi. Planta Med 77:749\u2013753","journal-title":"Planta Med"},{"key":"1142_CR34","first-page":"134","volume":"16","author":"SL Yoon","year":"2011","unstructured":"Yoon SL, Grundmann O, Koepp L, Farrell L (2011) Management of irritable bowel syndrome (IBS) in adults: conventional and complementary\/alternative approaches. Altern Med Rev 16:134\u2013151","journal-title":"Altern Med Rev"},{"key":"1142_CR35","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/jphp.12335","volume":"67","author":"M Zieli\u0144ska","year":"2015","unstructured":"Zieli\u0144ska M, Chen C, Mokrowiecka A, Cygankiewicz AI, Zakrzewski PK, Sa\u0142aga M, Ma\u0142ecka-Panas E, Wla\u017a P, Krajewska WM, Fichna J (2015) (2015). Orally administered novel cyclic pentapeptide P-317 alleviates symptoms of diarrhoea-predominant irritable bowel syndrome. J Pharm Pharmacol 67:244\u2013254","journal-title":"J Pharm Pharmacol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-015-1142-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-015-1142-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-015-1142-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T18:01:16Z","timestamp":1566842476000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-015-1142-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,12]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["1142"],"URL":"https:\/\/doi.org\/10.1007\/s00210-015-1142-1","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,12]]}}}